Your browser doesn't support javascript.
loading
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
Trentalange, Alice; Borgogno, Enrica; Motta, Ilaria; Antonucci, Miriam; Pirriatore, Veronica; Costa, Cecilia; Rossi, Giovanni; Barco, Ambra; De Nicolò, Amedeo; Piccioni, Pavilio; D'Avolio, Antonio; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea.
Afiliación
  • Trentalange A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy. Electronic address: alicetrenta@gmail.com.
  • Borgogno E; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Motta I; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Antonucci M; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Pirriatore V; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Costa C; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Rossi G; Unit of Pneumology, 'Amedeo di Savoia' Hospital, ASL 'Città di Torino', Torino, Italy.
  • Barco A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • De Nicolò A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Piccioni P; Unit of Pneumology, 'Amedeo di Savoia' Hospital, ASL 'Città di Torino', Torino, Italy.
  • D'Avolio A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Bonora S; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Di Perri G; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
Int J Antimicrob Agents ; 57(3): 106297, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33539932
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis / Isoniazida / Antituberculosos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis / Isoniazida / Antituberculosos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2021 Tipo del documento: Article